Seratrodast
SIGMA/SML1379 - ≥98% (HPLC)
Synonym: (±)
CAS Number: 112665-43-7
Empirical Formula (Hill Notation): C22H26O4
Molecular Weight: 354.44
MDL Number: MFCD00875701
Linear Formula: C22H26O4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C22H26O4/c1-14-15(2)22 |
| InChI key | ZBVKEHDGYSLCCC-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(C(C)=C1C)C(C)=C(C(CCC |
| solubility | DMSO: 25 mg/mL, clear |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Seratrodast is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist with anti-asthmatic activity. |
| Biochem/physiol Actions: | Seratrodast is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist with anti-asthmatic activity. Seratrodast inhibits the bronchconstriction induced by leukotriene D4 (LTD4), and platelet activating factor (PAF) with a long duration of action. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS08 |
| Signal word | Warning |
| Hazard statements | H361d |
| Precautionary statements | P201 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |


